Metropolitan Life Insurance CO Fibrogen Inc Transaction History

Metropolitan Life Insurance CO

  • $281 Million
  • Q3 2024

Shares

50 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
BUY
$0.73 - $2.73 $3,671 - $13,731
5,030 New
5,030 $11,000
Q1 2023

May 15, 2023
SELL
$15.95 - $25.18 $14,721 - $23,241
-923 Reduced 15.98%
4,854 $90,000
Q4 2022

Jun 14, 2023
BUY
$13.27 - $17.73 $12,248 - $16,364
923 Added 19.02%
5,777 $92.5 Million
Q3 2022

Jun 14, 2023
BUY
$11.4 - $14.6 $10,522 - $13,475
923 Added 19.02%
5,777 $75.2 Million
Q2 2022

Jun 20, 2023
BUY
$7.94 - $12.96 $7,328 - $11,962
923 Added 19.02%
5,777 $61,000
Q1 2022

Jun 20, 2023
BUY
$12.02 - $16.79 $11,094 - $15,497
923 Added 19.02%
5,777 $69,000
Q1 2022

Mar 30, 2023
SELL
$12.02 - $16.79 $168,147 - $234,875
-13,989 Reduced 70.77%
5,777 $69,000
Q1 2022

May 12, 2022
SELL
$12.02 - $16.79 $168,147 - $234,875
-13,989 Reduced 70.77%
5,777 $69,000
Q4 2021

Jun 21, 2023
BUY
$9.93 - $15.39 $148,076 - $229,495
14,912 Added 307.21%
19,766 $278,000
Q4 2021

Mar 30, 2023
SELL
$9.93 - $15.39 $7,725 - $11,973
-778 Reduced 3.79%
19,766 $278,000
Q4 2021

Feb 15, 2022
SELL
$9.93 - $15.39 $7,725 - $11,973
-778 Reduced 3.79%
19,766 $279,000
Q3 2021

Jun 21, 2023
BUY
$10.18 - $26.64 $159,724 - $417,981
15,690 Added 323.24%
20,544 $209,000
Q3 2021

Mar 30, 2023
SELL
$10.18 - $26.64 $40,658 - $106,400
-3,994 Reduced 16.28%
20,544 $209,000
Q3 2021

Nov 15, 2021
SELL
$10.18 - $26.64 $40,658 - $106,400
-3,994 Reduced 16.28%
20,544 $210,000
Q2 2021

Jun 21, 2023
BUY
$18.57 - $35.68 $365,531 - $702,325
19,684 Added 405.52%
24,538 $653,000
Q2 2021

Mar 30, 2023
BUY
$18.57 - $35.68 $29,284 - $56,267
1,577 Added 6.87%
24,538 $653,000
Q2 2021

Aug 16, 2021
BUY
$18.57 - $35.68 $455,243 - $874,695
24,515 Added 106586.96%
24,538 $653,000
Q1 2021

Jun 26, 2023
BUY
$31.0 - $55.72 $561,317 - $1.01 Million
18,107 Added 373.03%
22,961 $797 Million
Q1 2021

Mar 30, 2023
SELL
$31.0 - $55.72 $29,264 - $52,599
-944 Reduced 3.95%
22,961 $796,000
Q1 2021

May 14, 2021
SELL
$31.0 - $55.72 $740,342 - $1.33 Million
-23,882 Reduced 99.9%
23 $797,000
Q4 2020

Jun 22, 2023
BUY
$37.09 - $48.97 $706,601 - $932,927
19,051 Added 392.48%
23,905 $886,000
Q3 2020

Jun 26, 2023
BUY
$40.47 - $45.5 $770,993 - $866,820
19,051 Added 392.48%
23,905 $982,000
Q3 2020

Mar 30, 2023
SELL
$40.47 - $45.5 $56,415 - $63,427
-1,394 Reduced 5.51%
23,905 $982,000
Q3 2020

Nov 13, 2020
SELL
$40.47 - $45.5 $56,415 - $63,427
-1,394 Reduced 5.51%
23,905 $983,000
Q2 2020

Jun 26, 2023
BUY
$32.57 - $42.83 $665,893 - $875,659
20,445 Added 421.2%
25,299 $1.03 Million
Q2 2020

Mar 30, 2023
BUY
$32.57 - $42.83 $55,629 - $73,153
1,708 Added 7.24%
25,299 $1.03 Million
Q2 2020

Aug 14, 2020
BUY
$32.57 - $42.83 $55,629 - $73,153
1,708 Added 7.24%
25,299 $1.03 Million
Q1 2020

Jul 12, 2023
BUY
$23.3 - $45.96 $440,393 - $868,689
18,901 Added 389.39%
23,755 $825,000
Q1 2020

Mar 30, 2023
SELL
$23.3 - $45.96 $26,422 - $52,118
-1,134 Reduced 4.59%
23,591 $819,000
Q1 2020

May 15, 2020
SELL
$23.3 - $45.96 $26,422 - $52,118
-1,134 Reduced 4.59%
23,591 $820,000
Q4 2019

Jul 12, 2023
BUY
$34.58 - $48.06 $687,139 - $955,000
19,871 Added 409.37%
24,725 $1.06 Million
Q4 2019

Mar 30, 2023
SELL
$34.58 - $48.06 $17,601 - $24,462
-509 Reduced 2.02%
24,725 $1.06 Million
Q4 2019

Feb 14, 2020
SELL
$34.58 - $48.06 $17,601 - $24,462
-509 Reduced 2.02%
24,725 $1.06 Million
Q3 2019

Jul 12, 2023
BUY
$36.98 - $48.45 $753,652 - $987,411
20,380 Added 419.86%
25,234 $933,000
Q3 2019

Mar 30, 2023
BUY
$36.98 - $48.45 $40,899 - $53,585
1,106 Added 4.58%
25,234 $933,000
Q3 2019

Nov 14, 2019
BUY
$36.98 - $48.45 $40,899 - $53,585
1,106 Added 4.58%
25,234 $933,000
Q2 2019

Jul 12, 2023
BUY
$35.13 - $55.53 $677,095 - $1.07 Million
19,274 Added 397.07%
24,128 $1.09 Million
Q1 2019

Jul 13, 2023
BUY
$42.83 - $59.91 $825,505 - $1.15 Million
19,274 Added 397.07%
24,128 $1.31 Million
Q1 2019

Mar 30, 2023
BUY
$42.83 - $59.91 $785,973 - $1.1 Million
18,351 Added 317.66%
24,128 $1.31 Million
Q1 2019

May 16, 2019
SELL
$42.83 - $59.91 $1.82 Million - $2.54 Million
-42,451 Reduced 63.76%
24,128 $1.31 Million
Q1 2019

May 15, 2019
BUY
$42.83 - $59.91 $1.81 Million - $2.53 Million
42,166 Added 172.72%
66,579 $4.79 Million
Q4 2018

Jul 13, 2023
BUY
$37.97 - $60.16 $742,655 - $1.18 Million
19,559 Added 402.95%
24,413 $1.13 Million
Q4 2018

Feb 14, 2019
BUY
$37.97 - $60.16 $726,631 - $1.15 Million
19,137 Added 362.72%
24,413 $1.13 Million
Q3 2018

Jul 13, 2023
BUY
$56.3 - $67.25 $1.08 Million - $1.29 Million
19,236 Added 396.29%
24,090 $1.46 Billion
Q3 2018

Nov 14, 2018
SELL
$56.3 - $67.25 $1.06 Million - $1.27 Million
-18,814 Reduced 78.1%
5,276 $321,000
Q2 2018

Aug 15, 2018
BUY
$44.9 - $64.95 $93,885 - $135,810
2,091 Added 9.5%
24,090 $0
Q1 2018

May 15, 2018
BUY
$45.35 - $61.65 $24,035 - $32,674
530 Added 2.47%
21,999 $0
Q4 2017

Feb 15, 2018
SELL
$41.95 - $60.1 $973,533 - $1.39 Million
-23,207 Reduced 51.95%
21,469 $1.02 Million
Q3 2017

Nov 14, 2017
BUY
$33.4 - $53.9 $151,869 - $245,083
4,547 Added 11.33%
44,676 $2.4 Million
Q2 2017

Aug 14, 2017
BUY
N/A
40,129
40,129 $1.3 Million

Others Institutions Holding FGEN

# of Institutions
82
Shares Held
47.1M
Call Options Held
387K
Put Options Held
672K
View Full List

About FIBROGEN INC

FGEN Quotes by TradingView
  • Ticker FGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,741,200
  • Market Cap $32.8M
  • Description
  • FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...
More about FGEN
Track This Portfolio

Track Metropolitan Life Insurance CO Portfolio

Follow Metropolitan Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email